LifeMine Therapeutics
A therapeutics company founded in 2016 working in drug discovery and development using fungi. LifeMine uses genomics approaches to search for biosynthetic genes in eukaryotic microbes for the discovery of naturally inspired drugs to treat previously untreatable and significant chronic diseases.
3
Funding Rounds
$280.0m
Money raised
Overview
A therapeutics company founded in 2016 working in drug discovery and development using fungi. LifeMine uses genomics approaches to search for biosynthetic genes in eukaryotic microbes for the discovery of naturally inspired drugs to treat previously untreatable and significant chronic diseases.
- Website:
- Business model: B2B
- Headquarters: Cambridge, Massachusetts
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| We***** Zh** | - | - | - |
| Ri***** Kl****** | - | - | - |
| Gr** Ve***** | - | - | linkedin twitter |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ri***** Kl****** | - | - | - |
| Kr***** Ye****** | - | - | linkedin twitter |
| Gr***** Ve***** | - | - | - |
| Ed**** Hu | - | - |
Funding series
Funding Series Analysis
The company LifeMine Therapeutics has raised a total of $175m in funding over 3 rounds.
Key Insights:
- LifeMine Therapeutics Series C round, March 23, 2022: $175m
- LifeMine Therapeutics Series B round January 2021: $50m
- LifeMine Therapeutics funding round, September 2017: $55m
LifeMine Therapeutics Series C round, March 23, 2022
$175m
LifeMine Therapeutics Series B round January 2021
$50m
LifeMine Therapeutics funding round, September 2017
$55m
Industries
LifeMine Therapeutics is active in the following industries:
- Artificial Intelligence (AI)
- Software
- Technology
- Synthetic biology
- Biotechnology
- Biology
- Software development
- Machine learning
- Engineering
- Therapeutics
- Biomedical engineering
- Drug discovery
- Biopharmaceutical
- Pharmaceutical industry